Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritisRheumatology (Oxford, England), 2019-02, Vol.58 (Supplement_1), p.i43-i54 [Peer Reviewed Journal]The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. 2019 ;The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/key276 ;PMID: 30806709Full text available |
|
2 |
Material Type: Article
|
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of AmericaAmerican journal of respiratory and critical care medicine, 2019-10, Vol.200 (7), p.e45-e67 [Peer Reviewed Journal]Copyright American Thoracic Society Oct 1, 2019 ;Copyright © 2019 by the American Thoracic Society 2019 ;ISSN: 1073-449X ;EISSN: 1535-4970 ;DOI: 10.1164/rccm.201908-1581ST ;PMID: 31573350Full text available |
|
3 |
Material Type: Article
|
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug responseNature medicine, 2015-11, Vol.21 (11), p.1318-1325 [Peer Reviewed Journal]COPYRIGHT 2015 Nature Publishing Group ;COPYRIGHT 2015 Nature Publishing Group ;Copyright Nature Publishing Group Nov 2015 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/nm.3954 ;PMID: 26479923Full text available |
|
4 |
Material Type: Article
|
Therapeutic vaccines for cancer: an overview of clinical trialsNature reviews. Clinical oncology, 2014-09, Vol.11 (9), p.509-524 [Peer Reviewed Journal]COPYRIGHT 2014 Nature Publishing Group ;COPYRIGHT 2014 Nature Publishing Group ;Copyright Nature Publishing Group Sep 2014 ;Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. 2014. ;ISSN: 1759-4774 ;ISSN: 1759-4782 ;EISSN: 1759-4782 ;DOI: 10.1038/nrclinonc.2014.111 ;PMID: 25001465 ;CODEN: AJHYE6Full text available |
|
5 |
Material Type: Article
|
Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort studyAnnals of the rheumatic diseases, 2020-12, Vol.79 (12), p.1544-1549 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. https://bmj.com/coronavirus/usage? ;Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. 2020 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2020-218296 ;PMID: 32796045Full text available |
|
6 |
Material Type: Article
|
Biology and evolution of poorly differentiated neuroendocrine tumorsNature medicine, 2017-06, Vol.23 (6), p.1-673 [Peer Reviewed Journal]COPYRIGHT 2017 Nature Publishing Group ;COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Jun 2017 ;Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. 2017. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/nm.4341 ;PMID: 28586335Full text available |
|
7 |
Material Type: Article
|
Treatment of primary Sjögren syndromeNature reviews. Rheumatology, 2016-08, Vol.12 (8), p.456-471 [Peer Reviewed Journal]COPYRIGHT 2016 Nature Publishing Group ;Copyright Nature Publishing Group Aug 2016 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1759-4790 ;EISSN: 1759-4804 ;DOI: 10.1038/nrrheum.2016.100 ;PMID: 27411907Full text available |
|
8 |
Material Type: Article
|
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced CancerThe New England journal of medicine, 2012-06, Vol.366 (26), p.2455-2465 [Peer Reviewed Journal]Copyright © 2012 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;Copyright © 2012 Massachusetts Medical Society. 2012 ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1200694 ;PMID: 22658128 ;CODEN: NEJMAGFull text available |
|
9 |
Material Type: Article
|
Antiparasitic TherapyMayo Clinic proceedings, 2011-06, Vol.86 (6), p.561-583 [Peer Reviewed Journal]Mayo Foundation for Medical Education and Research ;2011 Mayo Foundation for Medical Education and Research ;2015 INIST-CNRS ;COPYRIGHT 2011 Elsevier, Inc. ;Copyright Mayo Foundation for Medical Education and Research Jun 2011 ;2011 Mayo Foundation for Medical Education and Research 2011 ;ISSN: 0025-6196 ;EISSN: 1942-5546 ;DOI: 10.4065/mcp.2011.0203 ;PMID: 21628620 ;CODEN: MACPAJFull text available |
|
10 |
Material Type: Article
|
Listeria monocytogenes-associated respiratory infections: a study of 38 consecutive casesClinical microbiology and infection, 2018-12, Vol.24 (12), p.1339.e1-1339.e5 [Peer Reviewed Journal]Attribution - NonCommercial ;ISSN: 1198-743X ;EISSN: 1469-0691 ;DOI: 10.1016/j.cmi.2018.03.003 ;PMID: 29549058Digital Resources/Online E-Resources |
|
11 |
Material Type: Article
|
Pine bark (Pinus spp.) extract for treating chronic disordersCochrane database of systematic reviews, 2020-09, Vol.2020 (9), p.CD008294 [Peer Reviewed Journal]Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD008294.pub5 ;PMID: 32990945Full text available |
|
12 |
Material Type: Article
|
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients seriesClinical rheumatology, 2020-11, Vol.39 (11), p.3195-3204 [Peer Reviewed Journal]The Author(s) 2020 ;The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0770-3198 ;EISSN: 1434-9949 ;DOI: 10.1007/s10067-020-05334-7 ;PMID: 32852623Full text available |
|
13 |
Material Type: Article
|
Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide AptamerJNCI : Journal of the National Cancer Institute, 2016-03, Vol.108 (3), p.djv330 [Peer Reviewed Journal]The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0027-8874 ;ISSN: 1460-2105 ;EISSN: 1460-2105 ;DOI: 10.1093/jnci/djv330 ;PMID: 26598503Full text available |
|
14 |
Material Type: Article
|
Potential therapeutic uses of BDNF in neurological and psychiatric disordersNature reviews. Drug discovery, 2011-03, Vol.10 (3), p.209-219 [Peer Reviewed Journal]COPYRIGHT 2011 Nature Publishing Group ;Copyright Nature Publishing Group Mar 2011 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/nrd3366 ;PMID: 21358740Full text available |
|
15 |
Material Type: Article
|
Pattern and diagnostic evaluation of systemic autoinflammatory diseases other than familial Mediterranean fever among Arab children: a multicenter study from the Pediatric Rheumatology Arab Group (PRAG)Rheumatology international, 2020, Vol.40 (1), p.49-56 [Peer Reviewed Journal]Springer-Verlag GmbH Germany, part of Springer Nature 2019 ;Rheumatology International is a copyright of Springer, (2019). All Rights Reserved. ;ISSN: 0172-8172 ;EISSN: 1437-160X ;DOI: 10.1007/s00296-019-04478-3 ;PMID: 31741047Full text available |
|
16 |
Material Type: Article
|
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trialNature medicine, 2020-06, Vol.26 (6), p.878-885 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2020. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-020-0880-x ;PMID: 32451495Full text available |
|
17 |
Material Type: Article
|
FIGHT-101, a first-in-human study of potent and selective FGFR 1-3 inhibitor pemigatinib in pan-cancer patients with FGF/FGFR alterations and advanced malignanciesAnnals of oncology, 2022-05, Vol.33 (5), p.522-533 [Peer Reviewed Journal]2022 The Authors ;Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2022.02.001 ;PMID: 35176457Full text available |
|
18 |
Material Type: Article
|
First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumoursBritish journal of cancer, 2020-12, Vol.123 (12), p.1730-1736 [Peer Reviewed Journal]The Author(s) 2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-020-01077-z ;PMID: 32989226Full text available |
|
19 |
Material Type: Article
|
Appropriate prescribing of oral beta-lactam antibioticsAmerican family physician, 2000-08, Vol.62 (3), p.611 [Peer Reviewed Journal]Copyright American Academy of Family Physicians Aug 1, 2000 ;ISSN: 0002-838X ;EISSN: 1532-0650 ;PMID: 10950216 ;CODEN: AFPYBFFull text available |
|
20 |
Material Type: Article
|
Long-term macrolide treatment for chronic respiratory diseaseThe European respiratory journal, 2013-07, Vol.42 (1), p.239-251 [Peer Reviewed Journal]2014 INIST-CNRS ;ISSN: 0903-1936 ;EISSN: 1399-3003 ;DOI: 10.1183/09031936.00136712 ;PMID: 23180583Full text available |